Abstract
The wide distribution in human body fluids and tissues of fibrinolysis activators most probably reflects their outstanding physiologic importance. The proteolytic activity of urine was discovered in 1861 by von Brücke, its ability to dissolve fibrin clots by Sahli in 1885. The existence of several proteolytic enzymes, some with pH optimum in the weak alkaline range, was soon recognized (Gehrig, 1886; Grützner, 1891).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Åstedt, B.: Release of plasminogen activators from isolated human glomeruli. Thrombos. Diathes. haemorrh. (Stuttg.) 34, 339 (1975)
Åstedt, B., Pandolfi, M., Nilsson, I. M.: Inhibitory effect of placenta on plasminogen activation in human organ culture. Proc. Soc. exp. Biol. (N.Y.) 139, 1421–1424 (1972)
Albrechtsen, O. K.: The fibrinolytic activity of animal tissues. Acta physiol. scand. 39, 284–290 (1957 a)
Albrechtsen, O. K.: The fibrinolytic activity of human tissues. Brit. J. Haemat. 3, 284–291 (1957b)
Ali S. Y., Evans, L.: Purification of rabbit kidney cytokinase and a comparison of its properties with human urokinase. Biochem. J. 107, 293–303 (1968)
Alkjaersig, N., Fletcher, A. P.: Metabolism of urokinase. In: Paoletti, R., Sherry, S. (Eds.): Thrombosis and Urokinase pp. 129–141 London: Academic Press. Proceedings of the Serono Symposia vol. 9, 1977
Alkjaersig, N., Fletcher, A. P., Sherry, S.: The activation of human plasminogen II. A kinetic study of activation with trypsin, urokinase and streptokinase. J. biol. Chem. 233, 86–90 (1958)
Alkjaersig, N., Fletcher, A. P., Sherry, S.: ε-Aminocaproic acid: an inhibitor of plasminogen activation. J. biol. Chem. 234, 832–837 (1959)
Alkjaersig, N., Fletcher, A. P., Sherry, S.: The assay of urokinase preparations for contamination with thromboplastic moieties. J. Lab. clin. Med. 65, 732–738 (1965)
Ambrus, C. M., Ambrus, J. L., Roholt, B. K., Shields, R. R.: Insolubilized activators of the fibrinolytic system: in vitro studies. J. Med. exp. clin. 3, 270–281 (1972b)
Ambrus, C. M., Roholt, O.A., Meyer, B. K.: Enzymatic activity of insolubilized streptokinase (I-SK) and urokinase (I-UK). Fed. Proc. 31, 267 (1972 a)
Andrassy, K., Ritz, E., Bleyl, U., Egbring, R.: Purification of human urokinase and its topographical localisation in renal parenchyma. Thrombos. Diathes. haemorrh. (Stuttg.) 34, 338 (1975)
Aoki, N., Kaulla, K. N. von: Dissimilarity of human vascular plasminogen activator and human urokinase. J. Lab. clin. Med. 78, 354–362 (1971)
Arnesen, H., Fagerhol, M. K.: α 2-Macroglobulin, α 1-antitrypsin and antithrombin III in plasma and serum during fibrinolytic therapy with urokinase Scand. J. clin. Lab. Invest. 29, 259–263 (1972)
Astrup, T., Stage, A.: Isolation of a soluble fibrinolytic activator from animal tissue. Nature (Lond.) 170, 929 (1952)
Astrup, T., Sterndorff, I.: An activator of plasminogen in normal urine. Proc. Soc. exp. Biol. (N.Y.) 81 675–678 (1952)
Astrup, T., Sterndorff, I.: Fibrinolysokinase activity in animal and human tissue. Acta physiol. scand. 37, 40–47 (1956)
Bachmann, F.: The role of the human liver in the regulation of thrombolytic activity. J. Lab. clin. Med. 68, 854–855 (1966)
Back, N., Ambrus, J. L., Muik, I. B.: Distribution and fate of I131-labeled compounds of the fibrinolysin system. Circulat. Res. 9, 1208–1216 (1961)
Ball, A. P., Day, E. D.: Urokinase-induced fibrinolysis of 125I-fibrin. Thrombos. Diathes. haemorrh. (Stuttg.) 24, 463–474 (1970)
Barlow, G. H., Lazer, L.: Characterization of the plasminogen activator isolated from human embryo kidney cells. comparison with urokinase. Thrombos. Res. 1, 201–208 (1972)
Barlow, G. H., Lazer, L., Rueter, A., Tribby, I.: Production of plasminogen activator by tissue culture techniques. In: Paoletti, R., Sherry, S. (Eds.): Thrombosis and Urokinase pp. 75–81 London: Academic Press. Proceedings of the Serono Symposia vol. 9, 1977
Barlow, G. H., Rueter, A., Tribby, I.: Production of plasminogen activator by tissue culture technique. In: Proteases and Biological Control, pp. 325–331. Cold Spring Habor Laboratory 1975
Barnett, E. V., Baron, S.: Cell culture produced activator for serum proteolytic proenzyme and its presence in poliomyelitis vaccine. Fed. Proc. 17, 503 (1958)
Barnett, E. V., Baron, S.: An activator of plasminogen produced by cell cultures. Proc. Soc. exp. Biol. (N.Y.) 102, 308–311 (1959)
Berg, W.: Activation of plasminogen and spontaneous inactivation of the plasmin formed. A kinetic study. Thrombos. Diathes. haemorrh. (Stuttg.) 19, 145–160 (1968 a)
Berg, W.: A method to correct for the continuing activation during the second stage in a two-stage assay. Thrombos. Diathes. haemorrh. (Stuttg.) 19, 161–168 (1968 b)
Berg, W., Korsan-Bengsten, K., Ygge, J.: Theoretical basis and standardization of the one-stage lysis time method for determination of urokinase. Thrombos. Diathes. haemorrh. (Stuttg.) 19, 169–177 (1968)
Bergstein, J. M., Michael, Jr., A. F.: Cortical fibrinolytic activity in normal and diseased human kidneys. J. Lab. clin. Med. 709, 701 (1972)
Bergstein, J. M., Michael, Jr. A. F.: Glomerular plasminogen activator activity in renal homograft rejection. Transplantation 17, 443–446 (1974)
Bergström, K.: A preparative method for the partial purification of human urokinase. Ark. Kemi 21, 535–546 (1963)
Bergström, K.: Purified bovine plasminogen preparation. N-terminal amino acid sequence, isoelectric point, and activation with urokinase. Ark. Kemi 21, 547–554 (1963)
Bernik, M. B.: Increased plasminogen activator (urokinase) in tissue cultures after fibrin deposition. J. clin. Invest. 52, 823–834 (1973)
Bernik, M. B., Kwaan, H. C.: Origin of fibrinolytic activity in cultures of the human kidney. J. Lab. clin. Med. 70, 650–661 (1967)
Bernik, M. B., Kwaan, H. C: Plasminogen activator activity in cultures from human tissues. An immunological and histochemical study. J. clin. Invest. 48, 1740–1753 (1969)
Bernik, M. B., White, W. F., Oller, E. P., Kwaan, H. C.: Immunologic identity of plasminogen activator in human urine, heart, blood vessels and tissue culture. J. Lab. clin. Med. 84, 546–558 (1974)
Bjerrehuus, I.: Fibrinolytic activity in urine. Scand. J. clin. Invest. 4, 179–182 (1952)
Blix, S.: The effectiveness of activators in clot lysis with special reference to fibrinolytic therapy. Acta med. scand. Suppl. 386, 1–24 (1962)
Boomgard, J., Vreeken, J., Bleyenberg, A., Deggeller, K.: Studies on urokinase. Some physiological considerations concerning normal urokinase excretion. Clin. chim. Acta 13, 484–490 (1966)
Boucher, B. J., Connolly, E. M., Farrow, S. C.: The use of intraarterial urokinase in a case of recurrent arterial occlusion. Postgrad. med. J. 49, 365–367 (1973)
Brakman, P., Astrup, T.: Selective inhibition in human pregnancy blood of urokinase induced fibrinolysis. Scand. J. clin. Lab. Invest. 15, 603–609 (1963)
Brochier, M., Griguer, P.: L’emploi de l’urokinase à doses modérées dans le traitement des embolies pulmonaires de haute gravité. Journées angéiologiques de langue française. Expansion scientifique. 82–86 (1974)
Brochier, M., Raynaud, R., Griguer, P., Fauchier, J.-P., Morand, Ph., Archamband, D., Ginies, G., Bienvenu, P.: Traitement thrombolytique par urokinase des embolies pulmonaires de haute gravité. Sem. Hôp. (Paris) 49, 1825–1836 (1973)
Brochier, M., Raynaud, R., Planiel, T., Fauchier, J. P., Griguer, P., Archamband, D., Pellois, A., Clisson, M.: Le traitment par l’urokinase des infarctus du myocarde et des syndromes de menace. Arch. Mal. Coeur 68, 563–569 (1975)
Brodrick, J. D., Hall, R. D.: Management and prognosis of secondary hyphaema. Proc. roy. Soc. Med. 64, 931–934 (1971)
Brooks, J., Davis, D., Devivo, G.: Blood hypercoagulability in acute cerebrovascular syndroms: its control with urokinase therapy. J. Lab. clin. Med. 76, 879–880 (1970)
Brücke, E. von: Die verdauende Substanz im Urin. S-B Akad. Wiss. (Wien) math.-nat. Kl. 43, 601 (1861)
Buluk, K., Furman, M.: On the controlling function of kidneys in fibrinolysis. Experientia (Basel) 18, 146–147 (1962)
Burges, R. A., Brammer, K. W., Coombes, J. D.: Molecular weight of urokinase. Nature (Lond.) 208, 894 (1965)
Camiolo, S. M., Thorsen, S., Astrup, T.: Fibrinogenolysis and fibrinolysis with tissue plasminogen activator, urokinase, streptokinase-activated human globulin and plasmin. Proc. Soc. exp. Biol. (N.Y.) 138, 277–280 (1971)
Capet-Antonini, F. C., Grimard, M., Tamenasse, J.: Properties of two types of solid-phase urokinase preparations.Thrombos. Res. 2, 479–486 (1973)
Celander, D. R., Guest, M. M.: Purification and properties of a urinary activation of plasma Profibrinolysin. Fed. Proc. 14, 27 (1955)
Celander, D. R., Langlinais, P., Guest, M. M.: The application of foam technique to the partial purification of urine activator of plasma Profibrinolysin. Arch. Biochem. 55, 286–287 (1955)
Celander, D. R., Schlagenhauf, G. K. Jr., Guest, M. M.: Purification of urokinase and some characteristics of the product. Thrombos. Diathes. haemorrh. (Stuttg.) 3, 359 (1959)
Cooley, R. N., Howard, M. D., De Groot, W. J., Dickie, K. J., Guest, M. M.: Angiographic observations on the treatment of pulmonary thromboembolism with urokinase. Amer. J. Roentgenol. 106, 576–590 (1969)
Crawford, G. P. M., Ogston, D.: The influence of α-1-antitrypsin on plasmin, urokinase and Hageman factor cofactor. Biochim. biophys. Acta (Amst.) 354, 107–113 (1974)
Day, E. D., Ball, A. P., Jeffords, D., Woodard, W. T., Jr., Silver, D.: The immunoassay of human urokinase. Thrombos. Diathes. haemorrh. (Stuttg.) 21, 273–286 (1969)
Deutsch, D. G., Mertz, E. T.: Activation of plasminogen with insoluble derivation of urokinase. J. Med. exp. clin. 3, 224–230 (1972)
Dickie, K. J., DeGroot, W. J., Cooley, R. N., Bond, T. P., Guest, M. M.: Hemodynamic effect of bolus infusion of urokinase in pulmonary embolism. Amer. Rev. resp. Dis. 109, 48–56 (1974)
Dickie, K. J., DeGroot, W. J., Cooley, R. N., Guest, M. M., Bond, T.: Urokinase in pulmonary thromboembolic disease: preliminary report. Tex. Rep. Biol. Med. 25, 613–624 (1967)
Doleschel, W., Auerswald, W.: Physiko-chemische Untersuchungen an humaner Urokinase mit besonderer Berücksichtigung ihres Verhaltens gegen Adsorbentien. Wien. Z. inn. Med. 41, 49–58 (1960)
Doleschel, W., Auerswald, W.: Determination of the molecular weights of uroprotein fractions with urokinase activity by means of molecular sieving. Med. Pharm. Exp. 16, 225–231 (1967)
Dubber, A. H. C., McNicol, G. P., Wilson, P. A., Douglas, A. S.: Studies with a preparation of urokinase. Thrombos. Diathes. haemorrh. (Stuttg.) 18, 133–149 (1967)
Duckert, F.: Lack of antigenicity of human urokinase. Unpublished data (1967)
Duckert, F., Bruhn, H. D.: Urokinase and plasmin assay. Unpublished data (1967)
Duckert, F., Gurland, H. J., Bounameaux, Y.: Urokinase in shunts. Unpublished data (1970)
Duckert, F., McNicol, G. P., Godal, H. C., Herold, R.: Influence of various initial doses of urokinase on coagulation parameters. Thrombos. Diathes. haemorrh. (Stuttg.) Suppl. 45, 23–36 (1971)
Duckert, F. Müller, G.: Thrombolysis and pulmonary embolism. Unpublished observations (1970)
DudokdeWit, C.: Investigations on the inhibition of the fibrinolytic system. Thrombos. Diathes. haemorrh. (Stuttg.) 12, 105–118 (1964)
DudokdeWit, C., Den Ottolander, G. J. H., Krijnen, H. W.: The measurement of fibrinolytic activity with I131-labeled clots. II. Application. Thrombos. Diathes. haemorrh. (Stuttg.) 8, 322–332 (1962)
Dugan, M. A., Kozar, J. J., Ganse, G., Charkes, N. D.: Localization of deep vein thrombosis using radioactive streptokinase. J. nucl. Med. 14, 233–234 (1973)
Dugmore, W. N., Raichand, M.: Intravitreal urokinase in treatment of vitreous haemorrhage. Lancet 1972/II, 660
Editorial Committee: The urokinase pulmonary embolism trial. A national cooperative study. Circulation 47, Suppl. 2, 1–108 (1973)
Editorial Committee: Urokinase-streptokinase embolism trial. A cooperative study. J. Amer. med. Ass. 229, 1606–1613 (1974)
Edwards, I. R., MacLean, K. S., Dow, J. D.: Low-dose urokinase in major pulmonary embolism. Lancet 1973/II, 409–413
European Collaborative Study: Controlled trial of urokinase in myocardial infarction. Lancet 1975/II, 624–626
Fischer, M., Pilgerstorfer, H. W.: Urokinase “Green Cross”, eine neue Urokinasepräparation. II In-vivo Untersuchungen. Int. J. clin. Pharmacol. 2, 142–149 (1969)
Fletcher, A. P., Alkjaersig, N.: Blood hypercoagulability, intravascular coagulation and thrombosis. New diagnostic concepts. Thrombos. Diathes. haemorrh. (Stuttg.) Suppl. 45, 389–394 (1971)
Fletcher, A. P., Alkjaersig, N.: Use of urokinase therapy in cerebrovascular disease. In: Paoletti, R., Sherry, S. (Eds.): Thrombosis and Urokinase pp. 203–215 London: Academic Press. Proceedings of the Serono Symposia vol. 9, 1977
Fletcher, A. P., Alkjaersig, N., Sherry, S., Genton, E., Hirsh, J., Bachmann, F.: The development of urokinase as a thrombolytic agent. Maintenance of a sustained thrombolytic state in man by its intravenous infusion. J. Lab. clin. Med. 65, 713–731 (1965)
Forbes, C. D., Turpie, A.G., McNicol, G. P.: Enhancement of the activity of optimum concentration of urokinase by the venom of Echis cannata. Nature (Lond.) 211, 989–990 (1966)
Forrester, J. V., Williamson, J.: Resolution of intravitreal clots by urokinase Lancet 1973II, 179–181
Gehrig, F.: Über Fermente im Harn. Pflügers Arch. ges. Physiol. 38, 35–93 (1886)
Genton, E., Claman, H. N.: Urokinase: Antigenic studies in patients following thrombolytic therapy. J. Lab. clin. Med. 75, 619–621 (1970)
Genton, E., Wolf, P. S.: Experimental pulmonary embolism: effects of urokinase therapy on organizing thrombi. J. Lab. clin. Med. 70, 311–325 (1967)
Genton, E., Wolf, P. S.: Urokinase therapy in pulmonary thromboembolism. Amer. Heart. J. 76, 628–637 (1968)
Geratz, J. D., Cheng, M. C.-F.: The inhibition of urokinase by aromatic diamidines. Thrombos. Diathes. haemorrh. (Stuttg.) 33, 230–243 (1975)
Gormsen, J., Tidstrøm, B., Feddersen, C., Ploug, J.: Biochemical evaluation of low dose of urokinase in acute myocardial infarction. Acta med. scand. 194, 191–198 (1973)
Greul, W., Tilsner, V.: Thrombolysis with urokinase in arterial and venous thrombosis. In: Paoletti, R., Sherry, S. (Eds.): Thrombosis and Urokinase pp. 235–242 London: Academic Press. Proceedings of the Serono Symposia vol. 9, 1977
Griguer, P.: L’augmentation de l’agréagation plaquettaire. Effet inattendu de la thérapeutique fibrinolytique. Ann. Cardiol. Angéiol. 22, 223–230 (1973)
Grützner, P.: Über Fermente im Harn. Dtsch. med. Wschr. 17, 10–13 (1891)
Guest, M. M., Celander, D. R.: Urokinase. Physiologic activator of Profibrinolysin. Tex. Rep. Biol. Med. 19, 89–105 (1961)
Hansen, P. F., Jørgensen, M., Kjeldgaard, N. O., Ploug, J.: Urokinase an activator of plasminogen from human urine. Eperiences with intravenous application on twenty-two patients. Angiology 12, 367–371 (1961)
Hashida, E., Maekawa, F., Mori, Y., Rin, K., Yamada, T.: Feasibility of urokinase in the treatment of acute myocardial infarction. Jap. Circulat. J. 36, 941–944 (1972)
Hedner, U., Nilsson, I. M.: Urokinase inhibitors in serum in a clinical series. Acta med. scand. 189, 185–189 (1971)
Hiemeyer, V., Rasche, H.: Vergleichende Untersuchungen zur Wirkung von Urokinase und Streptokinase im Tierversuch. Thrombos. Diathes. haemorrh. (Stuttg.) 17, 58–64 (1967)
Hilgard, O.: Comparative studies of the fibrinolytic system in rats and humans. Haemostasis 1, 101–107(1972)
Hisazumi, H., Naito, K., Misaki, T.: Fibrinolytic activity in normal and cancerous tissues of the bladder. Invest. Urol. 11, 28–34 (1973)
Holemans, R., Johnston, J. G., Reddick, R. L.: Release of plasminogen activator by the isolated perfused dog kidney. Nature (Lond.) 208, 291–292 (1965)
Holemans, R., McConnell, D., Johnston, J. G.: Urokinase levels in urine after nicotinic acid injection. Thrombos. Diathes. haemorrh. (Stuttg.) 15, 192–204 (1966)
Januszko, T., Furman, M., Buluk, K.: The kidneys and the liver as the organs regulating the fibrinolytic system of the circulating blood. Thrombos. Diathes. haemorrh. (Stuttg.) 15, 554–560 (1966)
Johnson, A. J., Kline, D. L., Alkjaersig, N.: Assay methods and standard preparations for plasmin, plasminogen and urokinase in purified systems, 1967–1968. Thrombos. Diathes. haemorrh. (Stuttg.) 21, 259–272 (1969)
Johnson, A. J., McCarty, W. R., Newman, J.: Thrombolysis in man with urokinase (UK). Proc. IXth Congr. Europ. Soc. Haemat. (Lissabon) p. 1389. Basel: Karger 1963b
Johnson, A. J., McCarty, W. R., Newman, J., Lackner, H.: Thrombolysis in man with urokinase. Blood 22, 829 (1963 a)
Johnson, A. J., Soberano, M. E., Ong, E. B., Levy, M., Schoellmann, G.: Urinary urokinase, two molecules or one? In: Paoletti, R., Sherry, S. (Eds.): Thrombosis and Urokinase pp. 59–67 London: Academic Press. Proceedings of the Serono Symposia vol. 9, 1977
Kaulla, K. N. von: Urin adsorbate with fibrinolytic and thromboplastic properties. J. Lab. clin. Med. 44, 944 (1954)
Kaulla, K. N. von: Methods for preparation of purified human thromboplastin and fibrinolysokinase from urine. Acta haemat. (Basel) 16, 315–321 (1956)
Kaulla, K. N. von: Components of the human fibrinolytic system in blood and urine and their relationship to therapeutic and spontaneous fibrinolysis. In: Page, I. H. (Ed.): Connective Tissue, Thrombosis and Atherosclerosis, pp. 259–279. New York: Academic Press 1959a
Kaulla, K. N. von: Urokinase studies. Thrombos. Diathes. haemorrh. (Stuttg.) 3, 358–359 (1959b)
Kaulla, K. N. von, Riggenbach, N.: Urokinase excretion in man: A method of determination and consideration of its significance. Thrombos. Diathes. haemorrh. (Stuttg.) 5, 162–178 (1960)
Kaulla, K. N. von, Schneeberger, E., Curry, M.: Quantitative determination of urokinase. Fed. Proc. 17, 167 (1958)
Kawano, T., Morimoto, K., Uemura, Y.: Urokinase inhibitor in human placenta. Nature (Lond.) 217, 253–254 (1968)
Kawano, T., Uemura, Y.: Inhibition of tissue activator by urokinase inhibitor. Thrombos. Diathes. haemorrh. (Stuttg.) 25, 129–133 (1971)
Kickhöfen, B., Struwe, F. E., Bramesfeld, B., Westphal, O.: Über einige Beobachtungen am Uropepsinogen und Plasminogen-Aktivator des menschlichen Urins. Biochem. Z. 330, 467–482 (1958)
Kjeldgaard, N. O., Ploug, J.: Urokinase. An activator of plasminogen from human urine. I. Mechanism of plasminogen activation. Biochim. biophys. Acta. (Amst.) 24, 283–289 (1957)
Koch, M., Binder, B., Auerswald, W.: Release of fibrinolytically active compounds during platelet-UK interactions. Thrombos. Diathes. haemorrh. (Stuttg.) 34, 318 (1975)
Kok, P., Astrup, T.: Isolation and purification of a tissue plasminogen activator and its comparison with urokinase. Biochemistry 8, 79–86 (1969)
Kucinski, C., Fletcher, A. P.: Immunologic distinction between human plasma plasminogen activator and human urokinase. Fed. Proc. 25, 194 (1966)
Kucinski, C., Fletcher, A. P.: Immunological studies with urokinase. Fed. Proc. 26, 647 (1967)
Kucinski, C., Fletcher, A. P., Sherry, S.: Effect of urokinase antiserum on plasminogen activators: Demonstration of immunologic dissimilarity between plasma plasminogen activator and urokinase. J. clin. Invest. 47, 1238–1253 (1968)
Kusserow, B. K., Larrow, R.: Use of surface bonded, covaiently crosslinked urokinase as an approach to the creation of a thromboresistant synthetic surface with fibrinolytic capability. Circulation 46, Suppl. 2, 11–54 (1972)
Kwaan, H. C.: Inhibitors of fibrinolysis. Thrombos. Res. 2, 31–40 (1973)
Kwaan, H. C., Dobbie, J. G., Fetkenhour, C. L.: The use of anticoagulants and thrombolytic agents in occlusive retinal vascular disease. In: Paoletti, R., Sherry, S. (Eds.): Thrombosis and Urokinase pp. 191–198 London: Academic Press. Proceedings of the Serono Symposia vol. 9, 1977
Kwaan, H. C., Fischer, S.: Localization of fibrinolytic activity in kidney tissues. Fed. Proc. 24, 387 (1965)
Ladehoff, A. A.: The content of plasminogen activator in the human urinary tract. Scand. J. clin. Invest. 12, 136–139 (1960)
Landmann, H.: Studies on the mechanism of action of synthetic antifibrinolytics. Thrombos. Diathes. haemorrh. (Stuttg.) 29, 253–275 (1973)
Landmann, H., Markwardt, F.: Irreversible synthetische Inhibitoren der Urokinase. Experientia (Basel) 26, 145–147(1970)
Laragh, J. H., Bär, L., Brunner, H. R., Bühler, F. R., Sealey, J. E., Darracott Vaughan, Jr., E.: Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Amer. J. Med. 52, 633–652 (1972)
Lesuk, A., Terminiello, L., Traver, J. H.: Crystalline human urokinase: some properties. Science 147, 880–882 (1965)
Lesuk, A., Terminiello, L., Traver, J. H.: Sephadex gel-filtration of human urokinase preparations. Fed. Proc. 25, 194 (1966)
Lesuk, A., Terminiello, L., Traver, J. H., LeGroff, J. L.: Proteolytic degradation of urokinase to active fragments. Fed. Proc. 26, 647 (1967)
Lesuk, A., Terminiello, L., Traver, J. H., LeGroff, J. L.: Biochemical and biophysical studies of human urokinase. Thrombos. Diathes. haemorrh. (Stuttg.) 18, 293–294 (1968)
Lipinski, B., Gurewich, V., Hyde, E.: Fibrinolysis versus fibrinogenolysis: the specificity of human vascular activator (VA) as compared to urokinase (UK) and streptokinase (SK). Thrombos. Diathes. haemorrh. (Stuttg.) 34, 351 (1975)
Litman, G. I., Smiley, R. B., Wenger, N. K.: The feasibility of urokinase therapy in acute myocardial infarction. Amer. J. Cardiol. 27, 636–640 (1971)
Lorand, L., Condit, E. V.: Ester hydrolysis by urokinase. Biochemistry 4, 265–270 (1965)
Lorand, L., Mozen, M. M.: Ester hydrolyzing activity of urokinase preparations. Nature (Lond.) 201, 392–393 (1964)
MacFarlane, R. G., Pilling, J.: Fibrinolytic activity of normal urine. Nature (Lond.) 159, 779 (1947)
Maciag, T., Mochan, B., Pye, E. K., Iyengar, M. R.: Plasminogen activator stimulation by plasma components in tissue culture. In: Paoletti, R., Sherry, S. (Eds.): Thrombosis and Urokinase, pp.103–118. London: Academic Press. Proceedings of the Serono Symposia, vol.9, 1977
McConnell, D., Johnston, D. G., Holemans, R., Cohen, L. A.: Blood plasminogen activator: mechanism of its release and lack of identity with urokinase. Fed. Proc. 25, 194 (1966a)
McConnell, D., Johnston, J. G., Young, I., Holemans, R.: Localization of plasminogen activator in kidney tissue. Lab. Invest. 15, 980–986 (1966b)
McKee, P. A., Lemmon, W. B., Hampton, J. W.: Streptokinase and urokinase activation of human, chimpanzee and baboon plasminogen. Thrombos. Diathes. haemorrh. (Stuttg.) 26, 512–522 (1971)
McNicol, G. P., Gale, S. B., Douglas, A. S.: In vitro and in vivo studies of a preparation of urokinase. Brit. med. J. 1963I, 909–915
Millar, W. T., Smith, J. F. B.: Localization of deep venous thrombosis using technetium-99m-labelled urokinase. Lancet 1974II, 695–696
Mohler, S. R., Celander, D. R., Guest, M. M.: Distribution of urokinase among mammals. Amer. J. Physiol. 192, 186–190 (1958)
Mootse, G., Marley, C., Cliffton, E. E.: Species-specific activation of plasminogen: comparison of human urokinase and cat urine. Amer. J. Physiol. 212, 657–661 (1967)
Müllertz, S.: Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin. Biochem. J. 143, 273–283 (1974)
Murray, J., Crawford, G. P. M., Ogston, D., Douglas, A. S.: Studies on an inhibitor of plasminogen activators in human platelets. Brit. J. Haemat. 26 661–668 (1974)
Nanninga, L. B., Guest, M. M.: Antiactivation (antikinase) activity of human plasma and its blocking by parachloromercuribenzoate and salicylate. Thrombos. Diathes. haemorrh. (Stuttg.) 26, 541–556 (1971)
Neidhart, P., Hofer, B., Duckert, F., Fridrich, R.: Die diagnostische Verwendung von 131I-Urokinase. Schweiz. med. Wschr. 104, 141–142 (1974)
Niewiarowski, S., Prokopowicz, J., Poplavski, A., Worowski, K.: Inhibition of dog fibrinolytic system in experimental tubular necrosis of kidney. Experientia (Basel) 20, 101–103 (1964)
Nishi, N., Tokura, S., Noguchi, J.: The synthesis of benzoyl-l arginine p-nitroanilide. Bull. chem. Soc. Jap. 43, 2900 (1970)
Ogawa, N., Yamamoto, H., Katamine, T., Tajima, H.: Purification and some properties of urokinase. Thrombos. Diathes. haemorrh. (Stuttg.) 34, 194–209 (1975)
Ogston, C. M., Ogston, D., Fullerton, H. W.: Observations on the lysis of artificial thrombi by urokinase. Thrombos. Diathes. haemorrh. (Stuttg.) 19, 107–116 (1968)
Ottolander, G. J. H., den, Leijnse, B., Cremer-Elfrink, H. M. J.: Plasmatic and platelet antiplasmins and anti-activators. Thrombos. Diathes. haemorrh. (Stuttg.) 18, 404–415 (1967)
Ottolander, G. J. H., den, Leijnse, B., Cremer-Elfrink, H. M. J.: Plasmatic and thrombotic antiplasmins and anti-activators II. Thrombos. Diathes. haemorrh. (Stuttg.) 21, 26–34 (1969 a)
Ottolander, G. J. H., den, Leijnse, B., Cremer-Elfrink, H. M. J.: Plasmatic and platelet anti-plasmins and anti-activators III. Thrombos. Diathes. haemorrh. (Stuttg.) 21, 35–41 (1969 b)
Painter, R. H., Charles, A. F.: Characterization of a soluble plasminogen activator from kidney cell cultures. Amer. J. Physiol. 202, 1125–1130 (1962)
Petkov, D., Christova, E., Karadjova, M.: Amidase activity of urokinase I. Hydrolysis of α-N-acetyl-L-lysine p-nitroanilide. Thrombos. Diathes. haemorrh. (Stuttg.) 29, 276–285 (1973)
Pierse, D., Legrice, H.: Urokinase in ophtalmology. Lancet 1963II, 1143–1144
Pierse, D., Legrice, H.: The use of urokinase in the anterior chamber of the eye. J. clin. Path. 17, 362 (1964)
Ploug, J., Kjeldgaard, N. O.: Isolation of a plasminogen activator (urokinase) from urine. Arch. Biochem. 62, 500 (1956)
Ploug, J., Kjeldgaard, N. O.: Urokinase. An activator of plasminogen from human urine. 1. Isolation and properties. Biochem. biophys. Acta (Amst.) 24, 278–282 (1957)
Prentice, C. R. M., Turpie, A. G. G., McNicol, G. P., Douglas, A.S.: Urokinase therapy: Dosage schedules and coagulant side effects. Brit. J. Haemat. 22, 567–577 (1972)
Pye, E. K., Maciag, T., Kelly, P., Iyengar, M. R.: Purification of urokinase by affinity chromatography. In: Paoletti, R., Sherry, S. (Eds.): Thrombosis and Urokinase pp. 43–58 London: Academic Press. Proceedings of the Serono Symposia vol. 9, 1977
Raab, W.: Die Urokinase des Meerschweinchens. Experientia (Basel) 20, 546–547 (1964)
Rakusin, W.: Urokinase in the management of traumatic hyphaema. Brit. J. Ophthal. 55, 826–832 (1971)
Rhodes, B. A., Turhisi, K. S., Bell, W. R., Wagner, H. N., Jr.: Radioactive urokinase for blood clot scanning. J. Nucl. Med. 13, 646–648 (1972)
Rickli, E. E., Otavsky, W. I.: Release of an N-terminal peptide from human plasminogen during activation with urokinase. Biochim. biophys. Acta. (Amst.) 295, 381–384 (1973)
Robbins, K. C., Summaria, L., Hsieh, B., Shak, R. J.: The peptide chains of human plasmin mechanism of activation of human plasminogen to plasmin. J. biol. Chem. 242, 2333–2342 (1967)
Roberts, H. R., Astrup, T.: Content of tissue activator of plasminogen in monkey tissues. Thrombos. Diathes. haemorrh. (Stuttg.) 1, 376–379 (1957)
Robinson, B. J., Glanville, J. N., Smith, P. H., Rosen, S. M.: Management of clotting in arteriovenous cannulae in patients on regular dialysis therapy. Brit. J. Urol. 42, 590–597 (1970)
Sahli, W.: Über das Vorkommen von Pepsin und Trypsin im normalen menschlichen Harn. Pflügers Arch. ges. Physiol. 36, 209–229 (1885)
Sasahara, A. A., Cannula, J. E., Belko, J. S., Morse, R. L., Criss, A. J.: Urokinase therapy in clinical pulmonary embolism. New Engl. J. Med. 277, 1168–1173 (1967)
Sautter, R. D., Emanuel, D. A., Fletcher, F. W., Wenzel, F. J., Matson, J. L: Urokinase for the treatment of acute pulmonary thromboembolism. J. Amer. med. Ass. 202, 215–218 (1967)
Sawyer, W. D., Alkjaersig, N., Fletcher, A. P., Sherry, S.: A comparison of the fibrinolytic and fibrinogenolytic effects of plasminogen activators and proteolytic enzymes in plasma. Thrombos. Diathes. haemorrh. (Stuttg.) 5, 149–161 (1961)
Sgouris, J. T., Inman, J. K., McCall, K. B.: The preparation of human urokinase. Amer. J. Cardiol. 6,406–408 (1960)
Sgouris, J. T., Storey, M. W., McCall, K. B., Anderson, H. D.: The purification, assay, sterilization and removal of pyrogenicity of human urokinase. Vox Sang. (Basel) 7, 739–749 (1962)
Sgouris, J. T., Taylor, H. L., McCall, K. B.: Urokinase activation of human plasminogen. National Meet. Amer. chem. Soc. 129, Abstr. 13 (1956)
Shaper, A. G., Macintosh, D. M., Kyobe, J.: Fibrinolytic activity in pregnancy during parturition and in the Puerperium. Lancet 1966II, 874–876
Sherry, S., Alkjaersig, N.: Studies on the activation of plasminogen (Profibrinolysin). J. clin. Invest. 35, 735 (1956)
Siegel, M. E., Malmud, L. S., Rhodes, B. A., Bell, W. S., Wagner, H. N., Jr.: Scanning of thromboemboli with 131I-streptokinase. Radiology 103, 695–696 (1972)
Silver, D.: Urokinase in the management of acute arterial and venous thrombosis. Arch. Surg. (Chic.) 97, 910–916 (1968)
Smyrniotis, F. E., Fletcher, A. P., Alkjaersig, N., Sherry, S.: Urokinase excretion in health and its alteration in certain disease states. Thrombos. Diathes. haemorrh. (Stuttg.) 3, 257–270 (1959)
Sobel, G. W., Mohler, S. R., Jones, N. W., Dowdy, A. B. C., Guest, M. M.: Urokinase: an activator of plasma Profibrinolysin extracted from urine. Amer. J. Physiol. 171, 768–769 (1952)
Sodetz, J., M., Castellino, F. J.: Mechanism of activation of rabbit plasminogen by urokinase. J. biol. Chem. 250, 3041 (1975)
Som, P., Rhodes, B. A., Bell, W. R.: Radiolabeled streptokinase and urokinase and their comparative biodistribution. Thrombos. Res. 6, 247–253 (1975)
Soong, B. C. F., Miller, S. P.: Coagulation disorders in cancer. III. Fibrinolysis and inhibitors. Cancer (Philad.) 25, 867–874 (1970)
Studer, R. O., Roncari, G., Lergier, W.: Characterization of urokinase from human urine. In: Paoletti, R., Sherry, S. (Eds.): Thrombosis and Urokinase pp. 89–90 London: Academic Press. Proceedings of the Serono Symposia vol. 9, 1977
Sturrock, R. D., Watkin, C., Williamson, T., Dick, W.C.: Intra-articular urokinase in rheumatical arthritis. Ann. rheum. Dis. 33, 124–125 (1974)
Svendsen, L., Senn, H. P., Amundsen, E.: Determination of urokinase and urinkallikrein by means of new chromogenic amide substrates, chromozym UK and chromozym GK. Int. Symp. on Vasopeptides (Fiesole) (1975)
Tajima, H., Ishiguro, J., Nonaka, R., Kurita, M., Tanaka, S., Ogawa, N.: Metabolic fate of urokinase. Chem. pharm. Bull. 22, 727–735 (1974)
Theiss, W., Gräff, H., Bleyl, U., Immich, H., Kuhn, W.: Reversible Stadien intravaskulärer Gerinnung und ihre Auswirkungen auf Nierenfunktion und Urokinaseausscheidung. Thrombos. Diathes. haemorrh. (Stuttg.) 23, 369–385 (1970)
Thorsen, S.: The inhibition of tissue plasminogen activator and urokinase induced fibrinolysis by some natural proteinase inhibitors and by plasma and serum from normal and pregnant subjects. Scand. J. clin. Lab. Invest. 31, 51–59 (1973)
Thorsen, S., Astrup, T.: Biphasic inhibition of urokinase-induced fibrinolysis by ε-aminocaproic acid; distinction from plasminogen tissue activator. Proc. Soc. exp. Biol. (N.Y.) 130, 811–814 (1969)
Thorsen, S., Astrup, T.: Substrate composition and the effect of ε-aminocaproic acid on tissue plasminogen activator and urokinase induced fibrinolysis. Thrombos. Diathes. haemorrh. (Stuttg.) 32, 306–324 (1974)
Thorsen, S., Glas-Greenwalt, P., Astrup, T.: Differences in the binding to fibrin of urokinase and tissue plasminogen activator. Thrombos. Diathes. haemorrh. (Stuttg.) 28, 65–74 (1972)
Todd, A. S.: Fibrinolysis autographs. Nature (Lond.) 181, 495–496 (1958)
Todd, A. S.: Localization of fibrinolytic activity in tissues. Brit. med. Bull. 20, 210–212 (1964)
Tow, D. E., Wagner, H. N., Holmes, R. A.: Urokinase in pulmonary embolism. New Engl. J. Med. 277, 1161–1167 (1967)
Tsapogas, M. J., Flute, P. T.: Experimental thrombolysis with streptokinase and urokinase. Brit. med. Bull. 20, 223–227 (1964)
Vreeken, J., Boomgard, J., Deggeler, K.: Urokinase excretion in patients with renal diseases. Acta med. scand. 180, 153–157 (1966)
Vukovich, T., Binder, B., Auerswald, W.: “Different” forms of urokinase. Thrombos. Diathes. haemorrh. (Stuttg.) 34, 338 (1975)
Walther, P. J., Steinman, H. M., Hill, R. L., McKee, P. A.: Activation of human plasminogen by urokinase. Partial characterization of a pre-activation peptide. J. biol. Chem. 249, 1173–1181 (1974)
Walton, P. L.: The hydrolysis of N-acetyl-glycyl-l-lysine methyl ester by urokinase. Biochim. biophys. Acta (Amst.) 132, 104–114 (1967)
White, W. F., Barlow, G. H., Mozen, M. M.: The isolation and characterization of plasminogen activators (urokinase) from human urine. Biochemistry 5, 2160–2169 (1966)
Williams, J. R. B.: The fibrinolytic activity of urine. Brit. J. exp. Path. 32, 530–537 (1951)
Williamson, J., Forrester, J. V.: Urokinase in the treatment of vitreous haemorrhage. Lancet 1972II, 488
Williamson, J., Forrester, J. V.: Treatment of vitreous haemorrhage with urokinase. Lancet 1973 II, 888
Wiman, B.: Primary structure of peptides released during activation of human plasminogen by urokinase. Europ. J. Biochem. 39, 1–9 (1973)
Wiman, B., Wallén, P.: Activation of human plasminogen by an insoluble derivative of urokinase. Europ. J. Biochem. 36, 25–31 (1973)
Witteween, S. A. G. J., Hemker, H. C., Hollaar, L., Hermens, W. T.: Quantitation of infarct size in man by means of plasma enzyme levels. Brit. Heart J. 37, 795–805 (1975)
Worowski, K., Niewiarowski, S., Prokopowicz, J.: Fibrinolysis and fibrinogen breakdown products (antithrombin VI) in renal venous blood (RVB) in dogs. Thrombos. Diathes. haemorrh. (Stuttg.) 12, 87–104 (1964)
Zubairov, D. M., Asadullin, M. G., Zinkevich, O. D., Chenborisova, G. S., Timerbaev, V. N.: Tshe isolation and some properties of human urokinase. Biokhimiya 39, 378–383 (1974)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Duckert, F. (1978). Urokinase. In: Markwardt, F. (eds) Fibrinolytics and Antifibrinolytics. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 46. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66863-0_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-66863-0_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66865-4
Online ISBN: 978-3-642-66863-0
eBook Packages: Springer Book Archive